Major depressive disorder and co-morbid chronic pain, a costly condition

被引：0
|
作者：
Hunkeler, EM
Arnow, BA
Fireman, B
Lee, J
Robinson, R
Blasley, C
Constantino, MJ
Kraemer, BC
Haywood, C
Dea, R
Swindle, RW
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Stanford Alcohol & Drug Treatment Ctr, Stanford, CA USA
[4] Stanford Med Ctr, Stanford, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [11] Probing the brain reward system in major depressive disorder, alcohol dependence and co-morbid individuals
    Balducci, X.
    Sproule, B.
    Chayab, L.
    Herrmann, N.
    Busto, U.
    Naranjo, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S255 - S255
  • [12] Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder
    Kim, J. W.
    Biederman, J.
    Arbeitman, L.
    Fagerness, J.
    Doyle, A. E.
    Petty, C.
    Perlis, R. H.
    Purcell, S.
    Smoller, J. W.
    Faraone, S. V.
    Sklar, P.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (06) : 781 - 790
  • [13] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [14] Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder
    Amsterdam, Jay D.
    Shults, Justine
    Rutherford, Nancy
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01): : 100 - 106
  • [15] Depressive disorders in primary care:: recurrent, chronic, and co-morbid
    Vuorilehto, M
    Melartin, T
    Isometsä, E
    PSYCHOLOGICAL MEDICINE, 2005, 35 (05) : 673 - 682
  • [16] Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness
    Baldwin, David S.
    Necking, Oscar
    Schmidt, Simon Nitschky
    Ren, Hongye
    Reines, Elin H.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 311 : 588 - 594
  • [17] FREQUENCY OF BIPOLAR AFFECTIVE DISORDER IN PATIENTS WITH MAJOR DEPRESSIVE EPISODE WITH OR WITHOUT PSYCHIATRIC CO-MORBID DISORDERS
    Kucukalic, Abdulah
    Bravo-Mehmedbasic, Alma
    Kulenovic, Alma Dzubur
    PSYCHIATRIA DANUBINA, 2012, 24 : S321 - S325
  • [18] Implicit alcohol cognitions in risky drinking nicotine users with and without co-morbid major depressive disorder
    Cohn, Amy M.
    Cobb, Caroline
    Hagman, Brett T.
    Cameron, Amy
    Ehlke, Sarah
    Mitchell, Jessica N.
    ADDICTIVE BEHAVIORS, 2014, 39 (04) : 797 - 802
  • [19] Functional Connectivity Abnormalities in Major Depressive Disorder With and Without Co-Morbid Borderline Personality Disorder and Implications for Treatment With TMS
    Dubin, Marc
    Ilieva, Irena
    Cochran, Ashley
    Liston, Conor
    Gunning, Faith
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S109 - S110
  • [20] COST OF CO-MORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL DEPENDENCE AMONG PATIENTS COVERED BY PRIVATE INSURANCE OR MEDICAID
    Chen, L.
    Wong, C. J.
    Kale-Wrobleski, K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 170A - 170A
12345